Portage Biotech Inc. (PRTG)
PRTG Stock Price Chart
Explore Portage Biotech Inc. interactive price chart. Choose custom timeframes to analyze PRTG price movements and trends.
PRTG Company Profile
Discover essential business fundamentals and corporate details for Portage Biotech Inc. (PRTG) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
2 Jan 2002
Employees
7.00
Website
https://www.portagebiotech.comCEO
Alexander Pickett
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
PRTG Financial Timeline
Browse a chronological timeline of Portage Biotech Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 11 Sept 2025
Earnings released on 26 Aug 2025
EPS came in at -$1.58 .
Earnings released on 28 Mar 2025
Earnings released on 26 Nov 2024
EPS came in at -$1.26 .
Earnings released on 15 Aug 2024
EPS came in at -$24.20 falling short of the estimated -$4.40 by -450.00%.
Stock split effective on 15 Aug 2024
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 6 Jun 2024
EPS came in at -$1.26 falling short of the estimated -$0.22 by -471.84%.
Earnings released on 28 Feb 2024
EPS came in at -$3.60 surpassing the estimated -$5.40 by +33.33%.
Earnings released on 28 Nov 2023
EPS came in at -$5.80 falling short of the estimated -$5.40 by -7.41%.
Earnings released on 30 Aug 2023
EPS came in at -$6.60 falling short of the estimated -$5.00 by -32.00%.
Earnings released on 31 Jul 2023
EPS came in at -$116.80 falling short of the estimated -$5.43 by -2.05K%.
Earnings released on 1 Mar 2023
EPS came in at -$8.80 falling short of the estimated -$4.60 by -91.30%.
Earnings released on 29 Nov 2022
EPS came in at -$1.20 surpassing the estimated -$5.40 by +77.78%.
Earnings released on 29 Aug 2022
EPS came in at -$2.60 surpassing the estimated -$7.00 by +62.86%.
Earnings released on 1 Aug 2022
EPS came in at -$11.00 falling short of the estimated -$0.39 by -2.70K%.
Earnings released on 24 Feb 2022
EPS came in at -$5.20 surpassing the estimated -$5.60 by +7.14%.
Earnings released on 23 Nov 2021
EPS came in at -$0.22 surpassing the estimated -$0.25 by +12.00%.
Earnings released on 30 Aug 2021
EPS came in at -$0.25 falling short of the estimated -$0.21 by -19.05%.
Earnings released on 29 Jul 2021
EPS came in at -$0.96 .
Earnings released on 1 Mar 2021
EPS came in at -$0.10 .
Earnings released on 16 Oct 2020
EPS came in at -$0.06 .
Earnings released on 15 Oct 2020
EPS came in at -$0.21 .
PRTG Stock Performance
Access detailed PRTG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.